The CBD Report 2018: Industry Outlook
- For the first time in 2017, U.S. hemp-derived CBD products outsold marijuana-derived CBD products.
- Marijuana-derived CBD branded sales grew from $64M in 2016 to $118M in 2017, a one-year increase of 84 percent. They will account for nearly 80 percent of the market versus flower by 2020.
- The anticipated rollout of Epidiolex in September will open the pharmaceutical channel; by 2022 the juvenile epilepsy treatment will account for approximately 1/3 of the total CBD market, netting estimated sales of over $625M.
The post Significant Growth is Expected with Branded Marijuana-Derived CBD Products appeared first on New Frontier.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!